Currently out of the existing stock ratings of Sebastian Sandler, 3 are a BUY (100%).

Sebastian Sandler

Work Performance Price Targets & Ratings Chart

Analyst Sebastian Sandler, currently employed at JPMORGAN, has had 100% of price targets met with an average potential upside of 24.84%, reached in 65 days on average.

Sebastian Sandler has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 06-May-2026.

Wall Street Analyst Sebastian Sandler

Analyst best performing recommendations are on ADPT (ADAPTIVE BIOTECHNOLOGIES CORP).
The best stock recommendation documented was for ADPT (ADAPTIVE BIOTECHNOLOGIES CORP) on 10/13/2025. The price target of $17 was fulfilled within 2 days with a profit of $1.5 (9.68%), with a performance score of 48.39.

Average potential price target upside

ADPT Adaptive Biotechnologies Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Sep-2025

$34

$4.96 (17.08%)

$32

6 days ago
(10-Nov-2026)

Buy Since 07-Oct-2020

$34

$4.96 (17.08%)

$25

1 months 25 days ago
(22-Sep-2026)

18/22 (81.82%)

$5.94 (21.17%)

247

Buy Since 08-May-2023

$27.5

$-1.54 (-5.30%)

$20

3 months 12 days ago
(04-Aug-2026)

15/15 (100%)

$2.95 (12.02%)

359

Buy Since 06-Aug-2025

$28

$-1.04 (-3.58%)

$21

3 months 17 days ago
(30-Jul-2026)

4/4 (100%)

$3.82 (15.80%)

78

Hold Since 09-Sep-2020

$18

$-2.96 (-14.12%)

$11

6 months 4 days ago
(12-May-2026)

12/16 (75%)

$4.37 (32.06%)

517

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Sebastian Sandler?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?